awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26829488-81DA67EE-6A97-417E-B5FC-990617116D9A
Q26829488-81DA67EE-6A97-417E-B5FC-990617116D9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829488-81DA67EE-6A97-417E-B5FC-990617116D9A
Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial
P2860
Q26829488-81DA67EE-6A97-417E-B5FC-990617116D9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829488-81DA67EE-6A97-417E-B5FC-990617116D9A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0fa70e1657abc99321d62aed9ac12413d6d37047
P2860
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.